Botanical Drug Approval Lower Efficacy Standard Endorsed By Purdue's Tyler
This article was originally published in The Tan Sheet
Executive Summary
FDA should require less stringent efficacy standards for OTC botanical drug products than are necessary for synthetic drugs, Purdue University's Varro Tyler, PhD, suggested at Nutracon 2001 in San Diego July 9.